Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1181

1.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Jan 29. pii: 10.1212/WNL.0000000000002395. [Epub ahead of print]

PMID:
26826205
2.

Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.

Chan A, de Seze J, Comabella M.

CNS Drugs. 2016 Jan;30(1):41-51. doi: 10.1007/s40263-015-0299-y.

3.

Grossesse et neuromodulation sacrée pour troubles vésico-sphinctériens : une étude nationale du comité de neuro-urologie de l'AFU.

Roulette P, Castel-Lacanal E, Phé V, Bart S, Caremel R, De Seze M, Duchene F, Even A, Manunta A, Sanson S, Loche C, Mouracade P, Rey D, Scheiber-Nogueira M, Kastler EC, Ruffion A, Karsenty G, Gamé X.

Prog Urol. 2015 Nov;25(13):848-9. doi: 10.1016/j.purol.2015.08.266. French. No abstract available.

PMID:
26544458
4.

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J.

J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3.

PMID:
26530512
5.

[The impact of mellitus diabetes on the lower urinary tract: A review of Neuro-urology Committee of the French Association of Urology].

Capon G, Caremel R, de Sèze M, Even A, Fontaine S, Loche CM, Bart S, Castel-Lacanal E, Duchêne F, Karsenty G, Mouracade P, Perrouin-Verbe MA, Phé V, Rey D, Scheiber-Nogueira MC, Gamé X.

Prog Urol. 2015 Oct 6. pii: S1166-7087(15)00594-1. doi: 10.1016/j.purol.2015.09.003. [Epub ahead of print] French.

PMID:
26452712
6.

Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.

Guffroy A, Dima A, Nespola B, Poindron V, Sibilia J, Herbrecht R, De Sèze J, Habersetzer F, Andres E, Quoix E, Ohlmann P, Cribier B, Langer B, Martin T, Pasquali JL, Goetz J, Korganow AS.

Joint Bone Spine. 2015 Sep 30. pii: S1297-319X(15)00151-7. doi: 10.1016/j.jbspin.2015.07.002. [Epub ahead of print]

PMID:
26433710
7.
8.

Neural correlates of episodic future thinking impairment in multiple sclerosis patients.

Ernst A, Noblet V, Gounot D, Blanc F, de Seze J, Manning L.

J Clin Exp Neuropsychol. 2015;37(10):1107-23. doi: 10.1080/13803395.2015.1080228.

PMID:
26378725
9.

Efficacy of rituximab in refractory neuromyelitis optica.

Collongues N, Brassat D, Maillart E, Labauge P, Ouallet JC, Carra-Dalliere C, Moreau T, Bourre B, Papeix C, Brochet B, Audoin B, Vukusic S, de Seze J, Marignier R; OFSEP and CFSEP.

Mult Scler. 2015 Sep 11. pii: 1352458515602337. [Epub ahead of print]

PMID:
26362900
10.

[Difficulties experienced at work by patients with multiple sclerosis].

Ongagna JC, Passadori A, Pinelli J, Isner-Horobeti ME, Zaenker C, De Seze J.

Rev Neurol (Paris). 2015 Nov;171(11):782-6. doi: 10.1016/j.neurol.2015.06.007. Epub 2015 Sep 3. French.

PMID:
26343923
11.

[Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey].

Peyronnet B, Sanson S, Amarenco G, Castel-Lacanal E, Chartier-Kastler E, Charvier K, Damphousse M, Denys P, de Seze M, Egon G, Even A, Forin V, Karsenty G, Kerdraon J, le Normand L, Loche CM, Manunta A, Mouracade P, Phe V, Previnaire JG, Ruffion A, Saussine C, Schurch B, Game X; et les membres du GENULF (Groupe d’étude de neuro-urologie de langue française) et du comité de neuro-urologie de l’AFU (Association française d’urologie).

Prog Urol. 2015 Dec;25(17):1219-24. doi: 10.1016/j.purol.2015.07.006. Epub 2015 Aug 28. French.

PMID:
26318394
12.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

13.

Characterization of morphological trunk changes in camptocormia patients.

Duarte R, Mesnard M, de Sèze M, Vignolles C, Wentzy P.

Comput Methods Biomech Biomed Engin. 2015;18 Suppl 1:1930-1. doi: 10.1080/10255842.2015.1069573. Epub 2015 Jul 28. No abstract available.

PMID:
26218478
14.

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Leray E, Vukusic S, Debouverie M, Clanet M, Brochet B, de Sèze J, Zéphir H, Defer G, Lebrun-Frenay C, Moreau T, Clavelou P, Pelletier J, Berger E, Cabre P, Camdessanché JP, Kalson-Ray S, Confavreux C, Edan G.

PLoS One. 2015 Jul 6;10(7):e0132033. doi: 10.1371/journal.pone.0132033. eCollection 2015.

15.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

16.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

PMID:
26010909
17.

Distinct and common cerebral activation changes during mental time travel in relapsing-remitting multiple sclerosis patients.

Ernst A, Noblet V, Denkova E, Blanc F, De Seze J, Gounot D, Manning L.

Brain Imaging Behav. 2015 May 15. [Epub ahead of print]

PMID:
25972116
18.

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Siri A, Carra-Dalliere C, Ayrignac X, Pelletier J, Audoin B, Pittion-Vouyovitch S, Debouverie M, Lionnet C, Viala F, Sablot D, Brassat D, Ouallet JC, Ruet A, Brochet B, Taillandier L, Bauchet L, Derache N, Defer G, Cabre P, de Seze J, Lebrun Frenay C, Cohen M, Labauge P.

J Neurol. 2015 Jul;262(7):1637-45. doi: 10.1007/s00415-015-7758-8. Epub 2015 May 1.

PMID:
25929666
19.

Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.

Lairy G, Zephir H, Ouallet JC, Le Page E, Laplaud D, Bensa C, De Seze J.

Rev Neurol (Paris). 2015 May;171(5):407-14. doi: 10.1016/j.neurol.2015.03.006. Epub 2015 Apr 23.

PMID:
25912471
20.

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.

Pröbstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T.

J Neuroinflammation. 2015 Mar 8;12:46. doi: 10.1186/s12974-015-0256-1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk